Let's compare this to RCPT with a $5 billion market cap and two drugs with much better safety profiles and potential peak sales estimates of $20 BILLION! Do the math and you'll know why the company wants $350/share as a takeover price and will likely get it!
The stock will most likely pop higher on the open tomorrow after Cramer's comments but then shorts will return and send it diving back down below it's 50 day ma into the daily uptrend line.
Be extremely patient if you insist on bottom fishing this stock. To many trapped longs are looking to get the heck out!
They have oral drugs with excellent safety profile that work better than current standard of care.
I'm really surprised that TEVA or BIIB hasn't offered the company the $300/share it wanted yet. It will surely happen in time, but the longer they wait, the higher the takeover price will go as the drugs go further along in development! :-)